In 2020 in the Eurozone's weakest economies, namely Portugal, Italy, Ireland, Greece, and Spain, the pharmaceutical market had a projected value of approximately 65 billion U.S. dollars. This statistic displays the value of the pharmaceutical sales in the Eurozone's weakest economies in 2011 and 2020.
Value of the pharmaceutical sales in the Eurozone's weakest economies* in 2011 and 2020 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in Spain
Overview
6
- Premium Statistic Revenues of top 10 global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Value of pharmaceutical sales in Spain 2008-2022
- Premium Statistic Pharmaceutical market in Spain 2023, by segment
- Basic Statistic Pharmacies in Spain 2007-2022
- Basic Statistic Employees in the Spanish pharmaceutical industry 2008-2021
International trade
6
- Premium Statistic Value of pharmaceutical products exported from Spain 2002-2022
- Premium Statistic Value of pharmaceutical products imported by Spain 2002-2022
- Premium Statistic Export value of pharmaceutical products in Spain 2022, by type
- Premium Statistic Import value of pharmaceutical products in Spain 2022, by type
- Premium Statistic Pharmaceutical exports value in Spain 2022, by country of destination
- Premium Statistic Pharmaceutical imports value in Spain 2022, by country of origin
Pharmaceutical sales
6
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2022
- Premium Statistic Net value of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Value share of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Volume of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Volume share of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Average price of drugs sold in pharmacies in Spain 2022, by therapeutic group
Pharmaceutical expenditure of the National Health System
6
- Premium Statistic Budget expenditure on health benefits & pharmacy in Spain 2003-2023
- Premium Statistic NHS expenditure on prescribed medicines in pharmacies in Spain 2010-2021
- Premium Statistic Average cost of medical prescriptions in pharmacies in Spain 2010-2021
- Premium Statistic State-funded drug prescriptions dispensed in pharmacies in Spain 2010-2021
- Premium Statistic NHS expenditure per prescription dispensed in pharmacies in Spain 2021, by region
- Premium Statistic Share of per capita pharmaceutical expenditure in Spain 2021, by region
Research and development
6
- Premium Statistic Share of total R&D spending in Spain in 2021, by industrial sector
- Premium Statistic R&D expenditure in the pharmaceutical industry in Spain 2008-2022
- Premium Statistic R&D employment within the pharmaceutical industry in Spain 2008-2022
- Premium Statistic Pharmaceutical R&D spending in Spain 2022, by type
- Premium Statistic Internal and external R&D expenditure in the pharmaceutical industry Spain 2012-2022
- Premium Statistic External R&D expenditure in the pharmaceutical industry Spain 2022, by region
Company rankings
6
- Premium Statistic Leading basic pharmaceutical products manufacturers in Spain in 2021
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2021
- Premium Statistic Leading pharmaceutical goods wholesalers in Spain in 2021
- Premium Statistic Corporate reputation of leading pharmaceutical companies in Spain in 2023
- Premium Statistic Leading companies in R&D on biotechnology in Spain 2021
- Basic Statistic Largest private capital increases of biotech companies in Spain 2021
Further related statistics
10
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Bingo revenue in Great Britain 2009-2022, by type
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
- Toiletry market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2009-2023
- Ethical personal products: spending in the United Kingdom (UK) 2011-2021
- Eni S.p.A.'s oil spills from operations 2009-2019
- Eni S.p.A.'s refinery throughputs 2009-2019
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Bingo revenue in Great Britain 2009-2022, by type
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
- Toiletry market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2009-2023
- Ethical personal products: spending in the United Kingdom (UK) 2011-2021
- Eni S.p.A.'s oil spills from operations 2009-2019
- Eni S.p.A.'s refinery throughputs 2009-2019
PwC, & Business Monitor International. (April 13, 2012). Value of the pharmaceutical sales in the Eurozone's weakest economies* in 2011 and 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/771704/pharmaceutical-industry-revenues-in-eurozones-weakest-economies/
PwC, und Business Monitor International. "Value of the pharmaceutical sales in the Eurozone's weakest economies* in 2011 and 2020 (in billion U.S. dollars)." Chart. April 13, 2012. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/771704/pharmaceutical-industry-revenues-in-eurozones-weakest-economies/
PwC, Business Monitor International. (2012). Value of the pharmaceutical sales in the Eurozone's weakest economies* in 2011 and 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/771704/pharmaceutical-industry-revenues-in-eurozones-weakest-economies/
PwC, and Business Monitor International. "Value of The Pharmaceutical Sales in The Eurozone's Weakest Economies* in 2011 and 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 13 Apr 2012, https://www.statista.com/statistics/771704/pharmaceutical-industry-revenues-in-eurozones-weakest-economies/
PwC & Business Monitor International, Value of the pharmaceutical sales in the Eurozone's weakest economies* in 2011 and 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/771704/pharmaceutical-industry-revenues-in-eurozones-weakest-economies/ (last visited June 10, 2024)
Value of the pharmaceutical sales in the Eurozone's weakest economies* in 2011 and 2020 (in billion U.S. dollars) [Graph], PwC, & Business Monitor International, April 13, 2012. [Online]. Available: https://www.statista.com/statistics/771704/pharmaceutical-industry-revenues-in-eurozones-weakest-economies/